Abstract
A large number of chemical compounds, including drugs of abuse and certain medications, have proven harmful effects on different components of the cardiovascular system, especially on the myocardium; hence, some authours use the term chemical cardiomyopathy to refer to these negative effects.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Afonso L, Mohammad T, Thatai D. Crack whips the heart: a review of the cardiovascular toxicity of cocaine. Am J Cardiol. 2007;100:1040–3.
Aquaro GD, Gabutti A, Meini M, Prontera C, et al. Silent myocardial damage in cocaine addicts. Heart. 2011;97:2056–62.
Benzaquen BS, Cohen V, Eisenberg MJ. Effects of cocaine on the coronary arteries. Am Heart J. 2001;142:402–10.
Bertolet BD, Freund G, Martin CA, Perchalski DL, Williams CM, Pepine CJ. Unrecognized left ventricular dysfunction in an apparently healthy alcohol abuse population. Drug Alcohol Depend. 1991;28:113–9.
Capasso JM, Li P, Guideri G. Myocardial mechanical, biochemical and structural alterations induced by chronic ethanol ingestion in rats. Circ Res. 1992;71:346–56.
Chatterjee K, Zhang J, Honbo N, Karliner JS. Doxorubicin cardiomyopathy. Cardiology. 2010;115:155–62.
Cohle SD. Fatal coronary artery intimal hyperplasia due to amphetamine use. Cardiovasc Pathol. 2013;22:e1–3.
Darke S, Kaye S, Duflou J. Cocaine-related fatalities in New South Wales, Australia 1993–2000. Drug Alcohol Depend. 2005;77:107–14.
de la Fuente L, Molist G, Espelt A, Barrio G, Guitart A, Bravo MJ, Brugal MT. Mortality risk factors and excess mortality in a cohort of cocaine users admitted to drug treatment in Spain. J Subst Abuse Treat. 2014;46(2):219–26.
Dettmeyer RB. Histopathology in drug abuse. In: Dettmeyes RB, editor. Forensic histopathology. Fundamentals and perspectives. Berlin/Heidelberg: Springer; 2011. p. 67–94.
Egred M, Davis GK. Cocaine and the heart. Postgrad Med J. 2005;81:568–71.
Fernandez-Sola J, Nicolas JM, Oriola J, Sacanella E, Estruch R, Rubin E, Urbano-Marquez A. Angiotensin-converting enzyme gene polymorphism is associated with vulnerability to alcoholic cardiomyopathy. Ann Intern Med. 2002;137:321–6.
Figueredo VM. Chemical cardiomyopathies: the negative effects of medications and nonprescribed drugs on the heart. Am J Med. 2011;124:480–8.
Galicia M, Nogué S, Burillo-Putze G. Ten years of emergency attendances for cocaine-users in Spain. Med Clin (Barc). 2014. doi:10.1016/j.medcli.2013.11.023 [Epub ahead of print].
Gill JR. The syndrome of excited delirium. Forensic Sci Med Pathol. 2014;10:223–8.
Guzzo-Merello G, Cobo-Marcos M, Gallego-Delgado M, Garcia-Pavia P. Alcoholic cardiomyopathy. World J Cardiology. 2014;6:771–81.
Guzzo-Merello G, Segovia J, Dominguez F, Cobo-Marcos M, Gomez-Bueno M, Avellana P, Millan I, Alonso-Pulpon L, Garcia-Pavia P. Natural history and risk factors in alcoholic cardiomyopathy. JACC Heart Failure. 2015 (in press).
Henning RJ, Li Y. Cocaine produces cardiac hypertrophy by protein kinase C dependent mechanisms. J Cardiovasc Pharmacol Ther. 2003;8:149–60.
Henning RJ, Cuevas J, Ivansicts D, Sanchez A. Cocaine activates calcium/calmodulin kinase II and causes cardiomyocyte hypertrophy. J Cardiovasc Pharmacol. 2006;48:802–13.
Henry CR, Satran D, Lindgren B, Adkinson C, Nicholson CI, Henry TD. Myocardial injury and long-term mortality following moderate to severe carbon monoxide poisoning. JAMA. 2006;295:398–402.
James TN. Small arteries of the heart. Circulation. 1977;56:2–14.
Karch SB. Cocaine cardiovascular toxicity. South Med J. 2005;98:794–9.
Karch SB. Cocaine. In: Karch SB, editor. Pathology of drugs of abuse. 4th ed. Boca Raton: CRC Press; 2009. p. 1–207.
Karch SB. The unique histology of methamphetamine cardiomyopathy: a case report. Forensic Sci Int. 2011;212:e1–4.
Karch SB, Green GS, Young S. Myocardial hypertrophy and coronary artery disease in male cocaine users. J Forensic Sci. 1995;40:591–5.
Karch SB, Stephens B, Ho CH. Relating cocaine blood concentrations to toxicity. An autopsy study of 99 cases. J Forensic Sci. 1998;43:41–5.
Knuepfer MM. Cardiovascular disorders associated with cocaine use: myths and truths. Pharmacol Ther. 2003;97:181–222.
Kolodgie FD, Virmani R, Cornhill JF, Herderick EE, Smialek J. Increase in atherosclerosis and adventitial mast cells in cocaine abusers: an alternative mechanism of cocaine-associated coronary vasospasm and thrombosis. J Am Coll Cardiol. 1991;17:1553–60.
Kolodgie FD, Wilson PS, Mergner WJ, Virmani R. Cocaine-induced increase in the permeability function of human vascular endothelial cell monolayers. Exp Mol Pathol. 1999;66:109–22.
Koponen H, Alaräisänen A, Saari K, Pelkonen O, Huikuri H, Raatikainen MP, Savolainen M, Isohanni M. Schizophrenia and sudden cardiac death. A review. Nord J Psychiatry. 2008;62:342–5.
Lacovoni A, De Mariab R, Gavazzia A. Alcoholic cardiomyopathy. J Cardiovasc Med (Hagerstown). 2010;11:884–92.
Lange R, Hillis N. Mechanism by which cocaine may induce myocardial infarction or ischemia. N Engl J Med. 2001;345:351–8.
Lazarevic AM, Nakatani S, Neskovic AN, et al. Early changes in left ventricular function in chronic asymptomatic alcoholics: relation to the duration of heavy drinking. J Am Coll Cardiol. 2000;35:1599–606.
Lippi G, Rastelli G, Meschi T, Borghi L, Cervellin G. Pathophysiology, clinics, diagnosis and treatment of heart involvement in carbon monoxide poisoning. Clin Biochem. 2012;45:1278–85.
Lucena J, Blanco M, Jurado C, Rico A, Salguero M, Vázquez R, Thiene G, Basso C. Cocaine-related sudden death: a prospective investigation in south-west Spain. Eur Heart J. 2010;31:318–29.
McKenna CJ, Codd MB, McCann HA, Sugrue DD. Alcohol consumption and idiopathic dilated cardiomyopathy: a case control study. Am Heart J. 1998;135:833–7.
Noord C, Sturkenboom MC, Straus SM, Witteman JC, Stricker BH. Non-cardiovascular drugs that inhibit HERG-encoded potassium channels and risk of sudden cardiac death. Heart. 2011;97:215–20.
Om A, Ellahham S, Vetrovev GW, Guard C, Reese S, Nixon JV. Left ventricular hypertrophy in normotensive cocaine users. Am Heart J. 1993;125:1441–3.
Patel MM, Belson MG, Wright D, Lu H, Heninger M, Miller MA. Methylenedioxymethamphetamine (ecstasy)-related myocardial hypertrophy: an autopsy study. Resuscitation. 2005;66:197–202.
Piano MR. Alcohol and heart failure. J Card Fail. 2002;8:239–46.
Ray WA, Chung CP, Murray KT, Hall K, Stein M. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med. 2009;360:225–35.
Robaei D, Grieve SM, Nelson GC, Bhindi R, Figtree GA. Cocaine-induced epicardial coronary artery thrombosis resulting in extensive myocardial injury assessed by cardiac magnetic resonance imaging. Eur Heart J. 2010;31:2446.
Sicouri S, Antzelevitch C. Sudden cardiac death secondary to antidepressant and antipsychotic drugs. Expert Opin Drug Saf. 2008;7:181–94.
Urbano-Marquez A, Estruch R, Navarro-Lopez F, Grau JM, Mont L, Rubin E. The effects of alcoholism on skeletal and cardiac muscle. N Engl J Med. 1989;320:409–15.
Virmani R, Robinowitz M, Smialek SE, Smyth DF. Cardiovascular effects of cocaine: an autopsy study of 40 patients. Am Heart J. 1988;115:1068–76.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Lucena, J.S., Garamendi, P.M., Guzzo-Merello, G., García-Pavía, P. (2015). Cardiovascular Pathology Secondary to Alcohol Consumption, Drugs of Abuse and Medication. In: Lucena, J., García-Pavía, P., Suarez-Mier, M., Alonso-Pulpon, L. (eds) Clinico-Pathological Atlas of Cardiovascular Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-11146-9_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-11146-9_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-11145-2
Online ISBN: 978-3-319-11146-9
eBook Packages: MedicineMedicine (R0)